Friday, December 12, 2025

Deloitte awarded $8.5M FDA Oncology Center of Excellence (OCE) Drug Labelling Initiative contract

Beating out two other bidders Deloitte has been awarded a 2-year Oncology Center of Excellence (OCE) Drug Labelling Initiative contract with the Food and Drug Administration. This contract was released on beta.SAM.

Awardee Name: DELOITTE CONSULTING LLP
Contract Duration: 24 months
Total Contract Value: $8,481,821.00
Action Obligation: $4,197,137.80
Funding Agency: FOOD AND DRUG ADMINISTRATION
Number of Bidders: 3
RFP ID: FDA-RFP-1227793
Award ID: 75F40120C00166

Deloitte, a global consulting and advisory services firm and major partner to FDA, was recently named to the updated list of NXT UP firms poised to make big waves in the Federal sector in 2020 and for years to come.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Innovation in Action: Advancing Government Health with Philips

FORUM is proud to partner with Philips for a series of articles on their groundbreaking innovations in health technology that serve public- and private sector citizens and service members. Please take a look to learn more about how Philips is advancing modern and efficient health care, while improving lives for generations to come.

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required